Emergency Medicine Reports - November 12, 2006

Target Audience:

This continuing medical education activity is intended for emergency physicians.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


J. Stephan Stapczynski, MD
Emergency Medicine Department
Maricopa Medical Center
Phoenix, Arizona

Sandra M. Schneider, MD
Professor and Chair
Department of emergency Medicine
University of Rochester School of Medicine
Rochester, New York

CME Question Reviewer
Roger Farel, MD
Newport Beach, California

Issue Editor
John W. Hafner, Jr., MD, FACEP
Clinical Assistant Professor of Surgery
Department of Emergency Medicine
University of Illinois
College of Medicine at Peoria
Director of Research
Emergency Medicine Residency
Attending Physician
OSF Saint Francis Hospital
Peoria, IL

Claire N. Kaplan, PhD
Sexual and Domestic Violence Services
University of Virginia Women's Center

Daisy Lovelace, MEd
University of Virginia

Leslie-Anne Pittard, MEd
University of Virginia

Dion Lewis, MEd
University of Virginia

Caitlin Corcoran
University of Virginia

Marcus L. Martin, MD
Professor and Chair
Department of Emergency Medicine
Assistant Dean
School of Medicine
Assistant Vice President
Office of Diversity and Equity
University of Virginia

Peer Reviewer
Ralph Riviello, MD, FACEP
Assistant Professor
Department of Emergency Medicine
Thomas Jefferson University
Philadelphia, PA


  • Domestic Violence and Intimate Partner Violence


  • quickly recognize or increase index of suspicion for specific conditions
  • understand the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed
  • understand the differential diagnosis of the entity discussed
  • understand both likely and rare complications that may occur

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that J. Stephan Stapczynski, MD (editor) served as a consultant to Pfizer on the drugs linezolid and dalbavancin, Roger Farel, MD (CME question reviewer) owns stock in Johnson & Johnson. John W. Hafner, Jr., MD, FACEP (issue editor), Sandra M. Schneider, MD (editor), Claire N. Kaplan, PhD, Daisy Lovelace, MEd, Leslie-Anne Pittard, MEd, Dion Lewis, MEd, Caitlin Corcoran, and Marcus L. Martin, MD (authors) report no relationships with companies related to the field of study covered by this CME activity. Ralph Riviello, MD, FACEP (peer reviewer) receives research support from Scios and GlaxoSmithKline.

Copyright 2006 AHC Media. All rights reserved.